| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Christian Sander | |
| Peter Schönknecht | |||
| Anja Tränkner | |||
| P2860 | cites work | Lamotrigine for treatment of bipolar depression: independent meta-analysis and meta-regression of individual patient data from five randomised trials | Q22241689 |
| Efficacy of antimanic treatments: meta-analysis of randomized, controlled trials | Q24601815 | ||
| Assessing the quality of reports of randomized clinical trials: is blinding necessary? | Q27860973 | ||
| A double-blind, placebo-controlled, prophylaxis study of lamotrigine in rapid-cycling bipolar disorder. Lamictal 614 Study Group | Q28139401 | ||
| Comparative efficacy and acceptability of antimanic drugs in acute mania: a multiple-treatments meta-analysis | Q28245879 | ||
| New data on the use of lithium, divalproate, and lamotrigine in rapid cycling bipolar disorder | Q30985990 | ||
| A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group. | Q33844681 | ||
| A placebo-controlled study of lamotrigine and gabapentin monotherapy in refractory mood disorders | Q33927263 | ||
| Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative | Q34026000 | ||
| Lamotrigine: a review of its use in bipolar disorder | Q34228876 | ||
| The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders, Part II: Treatment of Mania | Q34531273 | ||
| The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders, part III: maintenance treatment | Q34550618 | ||
| The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2009 on the treatment of acute mania | Q34606256 | ||
| Lamotrigine update and its use in mood disorders | Q34615607 | ||
| The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2010 on the treatment of acute bipolar depression | Q34616633 | ||
| Synaptic, intracellular, and neuroprotective mechanisms of anticonvulsants: are they relevant for the treatment and course of bipolar disorders? | Q34726336 | ||
| Adjunctive treatment for mood stabilization of patients with bipolar I disorder treated with lamotrigine. | Q50926783 | ||
| Effects of lamotrigine in patients with bipolar disorder and alcohol dependence. | Q51917535 | ||
| S3-Leitlinie zur Diagnostik und Therapie bipolarer Störungen | Q56753121 | ||
| Tranylcypromine vs. lamotrigine in the treatment of refractory bipolar depression: a failed but clinically useful study | Q60646350 | ||
| The efficacy of lamotrigine in rapid cycling and non–rapid cycling patients with bipolar disorder | Q63446703 | ||
| Addition of lamotrigine to valproate may enhance efficacy in the treatment of bipolar affective disorder | Q71734285 | ||
| Lamotrigine treatment of rapid cycling bipolar disorder | Q73565197 | ||
| Combined olanzapine plus fluoxetine modestly improves symptoms of acute bipolar I depression compared to lamotrigine | Q79666581 | ||
| Randomized, double-blind pilot trial comparing lamotrigine versus citalopram for the treatment of bipolar depression | Q79838130 | ||
| Long-term lamotrigine plus lithium for bipolar disorder: One year outcome | Q80336449 | ||
| Lack of mania prophylaxis associated with lamotrigine monotherapy in manic-predominant bipolar I disorder | Q80530180 | ||
| Ministry of Health clinical practice guidelines: bipolar disorder | Q82904716 | ||
| Lamotrigine in the acute treatment of bipolar depression: results of five double-blind, placebo-controlled clinical trials | Q34749757 | ||
| Mood stabilization and destabilization during acute and continuation phase treatment for bipolar I disorder with lamotrigine or placebo | Q34998093 | ||
| World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of bipolar disorders. Part I: Treatment of bipolar depression | Q35024109 | ||
| Pharmacotherapy for the treatment of acute bipolar II depression: current evidence | Q35954969 | ||
| The use of placebo in clinical trials on bipolar disorder: a new approach for an old debate | Q35997742 | ||
| Anticonvulsant treatments of dysphoric mania: a trial of gabapentin, lamotrigine and carbamazepine in Iran | Q36836746 | ||
| Pharmacological interventions for acute bipolar mania: a systematic review of randomized placebo-controlled trials | Q36936379 | ||
| Role of lamotrigine in the management of treatment-resistant bipolar II depression: a chart review | Q37099989 | ||
| A single blind comparison of lithium and lamotrigine for the treatment of bipolar II depression | Q37107425 | ||
| Evidence-based guidelines for treating bipolar disorder: revised second edition--recommendations from the British Association for Psychopharmacology | Q37426143 | ||
| Lamotrigine: when and where does it act in affective disorders? A systematic review | Q37786119 | ||
| Safety and tolerability of lamotrigine: results from 12 placebo-controlled clinical trials and clinical implications | Q37829608 | ||
| Efficacy and safety of lamotrigine as add-on treatment to lithium in bipolar depression: a multicenter, double-blind, placebo-controlled trial | Q38383812 | ||
| Adjunctive lamotrigine therapy for patients with bipolar II depression partially responsive to mood stabilizers. | Q38482997 | ||
| Clinical predictors of response to lamotrigine and gabapentin monotherapy in refractory affective disorders | Q40661158 | ||
| Lamotrigine. An update of its pharmacology and therapeutic use in epilepsy | Q40932340 | ||
| Spectrum of activity of lamotrigine in treatment-refractory bipolar disorder | Q42605435 | ||
| A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder. | Q42613693 | ||
| A pooled analysis of 2 placebo-controlled 18-month trials of lamotrigine and lithium maintenance in bipolar I disorder. | Q42625302 | ||
| Lamotrigine compared with lithium in mania: a double-blind randomized controlled trial | Q42625897 | ||
| An open longitudinal study of patients with bipolar rapid cycling treated with lithium or lamotrigine for mood stabilization | Q42645137 | ||
| Lamotrigine in rapid-cycling bipolar disorder | Q42671686 | ||
| Lamotrigine versus lithium as maintenance treatment in bipolar I disorder: an open, randomized effectiveness study mimicking clinical practice. The 6th trial of the Danish University Antidepressant Group (DUAG-6). | Q42672212 | ||
| The effect of dermatologic precautions on the incidence of rash with addition of lamotrigine in the treatment of bipolar I disorder: a randomized trial. | Q42684486 | ||
| Olanzapine or lamotrigine addition to lithium in remitted bipolar disorder patients with anxiety disorder comorbidity: a randomized, single-blind, pilot study. | Q43970829 | ||
| A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder | Q44403599 | ||
| Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009. | Q45484599 | ||
| A non-randomized study to investigate the effects of the atypical antipsychotic aripiprazole on the steady-state pharmacokinetics of lamotrigine in patients with bipolar I disorder | Q46170156 | ||
| Olanzapine/fluoxetine combination vs. lamotrigine in the 6-month treatment of bipolar I depression | Q46200033 | ||
| Antidepressant-like effect of lamotrigine is reversed by veratrine: a possible role of sodium channels in bipolar depression | Q46629165 | ||
| Treatment-resistant bipolar depression: a STEP-BD equipoise randomized effectiveness trial of antidepressant augmentation with lamotrigine, inositol, or risperidone | Q46921502 | ||
| Impact of lamotrigine and lithium on weight in obese and nonobese patients with bipolar I disorder | Q47331378 | ||
| Long-term outcome of bipolar depressed patients receiving lamotrigine as add-on to lithium with the possibility of the addition of paroxetine in nonresponders: a randomized, placebo-controlled trial with a novel design | Q48910862 | ||
| A 7-week, randomized, double-blind trial of olanzapine/fluoxetine combination versus lamotrigine in the treatment of bipolar I depression. | Q50278208 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | bipolar disorder | Q131755 |
| lamotrigine | Q410346 | ||
| P304 | page(s) | 101-111 | |
| P577 | publication date | 2013-01-18 | |
| P1433 | published in | Neuropsychiatric Disease and Treatment | Q15716332 |
| P1476 | title | A critical review of the recent literature and selected therapy guidelines since 2006 on the use of lamotrigine in bipolar disorder | |
| P478 | volume | 9 |
| Q37643038 | Clinical Practice Guidelines for Management of Bipolar Disorder |
| Q40695477 | Differences between bipolar and unipolar depression on Rorschach testing. |
| Q33673618 | Olanzapine is superior to lamotrigine in the prevention of bipolar depression: a naturalistic observational study. |
| Q37134756 | Revisiting the Lamotrigine-Mediated Effect on Hippocampal GABAergic Transmission |
| Q34331882 | The diagnosis and treatment of bipolar disorder: decision-making in primary care |
Search more.